PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$87.06M
Total Shares
26.46M
Net Share Change
+10.19M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Patient Capital Management
$87.06M26.46M shares
ADD+10.19M(+62.6%)